Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2025 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

stepan co. - SCL

SCL

Close Chg Chg %
48.25 0.12 0.25%

Closed Market

48.37

+0.12 (0.25%)

Volume: 187.77K

Last Updated:

Dec 16, 2025, 4:00 PM EDT

Trade Now

Company Overview: stepan co. - SCL

SCL Key Data

Open

$48.26

 Day Range

47.69 - 48.77

52 Week Range

41.82 - 72.96

 Market Cap

$1.09B

Shares Outstanding

22.62M

 Public Float

21.56M

Beta

1.05

 Rev. Per Employee

N/A

P/E Ratio

24.28

 EPS

$1.98

Yield

322.98%

 Dividend

$0.40

EX-DIVIDEND DATE

Nov 28, 2025

 SHORT INTEREST

N/A

AVERAGE VOLUME

171.20K

  

SCL Performance

1 Week
 
 0.44%
 
1 Month
 
 9.12%
 
3 Months
 
 -0.74%
 
1 Year
 
 -34.48%
 
5 Years
 
 -59.26%
 

SCL Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 1
Full Ratings ➔

About stepan co. - SCL

Stepan Co. engages in the manufacture and sale of specialty and intermediate chemicals. It operates through the following segments: Surfactants, Polymers, and Specialty Products. The Surfactants segment products are used in consumer and industrial cleaning and disinfection products, agricultural products, lubricating ingredients, oil field chemicals, and other applications. The Polymers segment deals mainly with rigid foam for thermal insulation in the construction industry, plastics, building materials, refrigeration systems, and CASE applications. The Specialty Products segment consists of chemicals used in food, flavoring, nutritional supplements, and pharmaceutical applications. The company was founded by Alfred C. Stepan Jr. in 1932 and is headquartered in Northbrook, IL.

SCL At a Glance

Stepan Co.
1101 Skokie Boulevard
Northbrook, Illinois 60062
Phone 1-847-446-7500 Revenue 2.18B
Industry Chemicals: Specialty Net Income 50.37M
Sector Process Industries Employees 2,396
Fiscal Year-end 12 / 2025
View SEC Filings

SCL Valuation

P/E Current 24.28
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 29.455
Price to Sales Ratio 0.68
Price to Book Ratio 1.244
Price to Cash Flow Ratio 9.16
Enterprise Value to EBITDA 10.989
Enterprise Value to Sales 0.955
Total Debt to Enterprise Value 0.335

SCL Efficiency

Revenue/Employee 909,964.107
Income Per Employee 21,022.538
Receivables Turnover 5.619
Total Asset Turnover 0.934

SCL Liquidity

Current Ratio 1.211
Quick Ratio 0.78
Cash Ratio 0.149

SCL Profitability

Gross Margin 12.485
Operating Margin 3.544
Pretax Margin 2.772
Net Margin 2.31
Return on Assets 2.158
Return on Equity 4.221
Return on Total Capital 2.697
Return on Invested Capital 3.113

SCL Capital Structure

Total Debt to Total Equity 59.662
Total Debt to Total Capital 37.368
Total Debt to Total Assets 30.287
Long-Term Debt to Equity 33.337
Long-Term Debt to Total Capital 20.88
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Stepan Co. - SCL

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
2.35B 2.77B 2.33B 2.18B
Sales Growth
+25.47% +18.21% -16.14% -6.26%
Cost of Goods Sold (COGS) incl D&A
1.95B 2.35B 2.05B 1.91B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
90.88M 94.65M 105.34M 112.20M
Depreciation
83.58M 87.81M 97.97M 105.28M
Amortization of Intangibles
7.29M 6.83M 7.37M 6.91M
COGS Growth
+31.22% +20.31% -12.70% -6.84%
Gross Income
395.80M 427.06M 277.59M 272.20M
Gross Income Growth
+3.18% +7.90% -35.00% -1.94%
Gross Profit Margin
+16.87% +15.40% +11.94% +12.48%
2021 2022 2023 2024 5-year trend
SG&A Expense
221.68M 218.45M 204.98M 194.93M
Research & Development
62.69M 66.63M 59.04M 55.67M
Other SG&A
158.99M 151.81M 145.94M 139.26M
SGA Growth
+5.12% -1.46% -6.17% -4.90%
Other Operating Expense
- - - -
-
Unusual Expense
3.35M 1.29M 14.01M 6.80M
EBIT after Unusual Expense
170.77M 207.33M 58.60M 70.47M
Non Operating Income/Expense
8.77M (7.74M) 5.73M 9.43M
Non-Operating Interest Income
4.14M 2.84M 4.70M 6.58M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
7.01M 10.89M 15.95M 19.46M
Interest Expense Growth
-7.55% +55.38% +46.44% +22.07%
Gross Interest Expense
10.14M 17.85M 29.36M 33.03M
Interest Capitalized
3.14M 6.96M 13.41M 13.56M
Pretax Income
172.54M 188.70M 48.39M 60.44M
Pretax Income Growth
+0.86% +9.37% -74.36% +24.90%
Pretax Margin
+7.35% +6.80% +2.08% +2.77%
Income Tax
34.64M 41.55M 8.19M 10.07M
Income Tax - Current - Domestic
44.38M 49.20M (23.40M) 1.70M
Income Tax - Current - Foreign
23.87M 19.80M 13.29M 18.66M
Income Tax - Deferred - Domestic
(32.21M) (27.58M) 20.71M (6.34M)
Income Tax - Deferred - Foreign
(1.40M) 127.00K (2.41M) (3.95M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
137.90M 147.15M 40.20M 50.37M
Minority Interest Expense
- - - 91.00K
-
Net Income
137.80M 147.15M 40.20M 50.37M
Net Income Growth
+8.70% +6.78% -72.68% +25.29%
Net Margin Growth
+5.87% +5.31% +1.73% +2.31%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
137.80M 147.15M 40.20M 50.37M
Preferred Dividends
- - - -
-
Net Income Available to Common
137.80M 147.15M 40.20M 50.37M
EPS (Basic)
6.0119 6.4595 1.7651 2.2061
EPS (Basic) Growth
+8.83% +7.45% -72.67% +24.98%
Basic Shares Outstanding
22.92M 22.78M 22.78M 22.83M
EPS (Diluted)
5.9176 6.3802 1.7521 2.1966
EPS (Diluted) Growth
+8.56% +7.82% -72.54% +25.37%
Diluted Shares Outstanding
23.29M 23.06M 22.95M 22.93M
EBITDA
265.00M 303.26M 177.95M 189.47M
EBITDA Growth
+4.09% +14.44% -41.32% +6.47%
EBITDA Margin
+11.30% +10.94% +7.65% +8.69%

Snapshot

Average Recommendation HOLD Average Target Price 85.00
Number of Ratings 1 Current Quarters Estimate 0.395
FY Report Date 12 / 2025 Current Year's Estimate 2.245
Last Quarter’s Earnings 0.48 Median PE on CY Estimate N/A
Year Ago Earnings 2.20 Next Fiscal Year Estimate 3.515
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 2 2 2 2
Mean Estimate 0.40 0.91 2.25 3.52
High Estimates 0.44 1.01 2.29 3.62
Low Estimate 0.35 0.81 2.20 3.41
Coefficient of Variance 16.11 15.54 2.83 4.22

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 0 0 0
OVERWEIGHT 0 0 0
HOLD 1 1 1
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Hold Hold Hold

Insider Actions for Stepan Co. - SCL

Date Name Shares Transaction Value
Aug 13, 2025 Joaquin Delgado Director 16,071 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $54.26 per share 872,012.46
Aug 13, 2025 Corning F. Painter Director 2,433 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $49.09 per share 119,435.97
Aug 13, 2025 Ruben Dario Velasquez VP and Chief Financial Officer 5,714 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Aug 13, 2025 Ruben Dario Velasquez VP and Chief Financial Officer 2,037 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Aug 13, 2025 Ruben Dario Velasquez VP and Chief Financial Officer 4,074 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 22, 2025 Robert J. Haire EVP, Supply Chain 591 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $51.86 per share 30,649.26
May 22, 2025 Robert J. Haire EVP, Supply Chain 550 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 4, 2025 Edward Joseph Wehmer Director 15,281 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 4, 2025 Lorinda A. Burgess Director 1,427 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 4, 2025 Randall S. Dearth Director 1,347 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 24, 2025 Sharon N. Purnell VP & CHRO N/A Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 0.00
Mar 24, 2025 Samuel S. Hinrichsen VP & Interim CFO N/A Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 0.00
Mar 24, 2025 Richard Finn Stepan V.P. and Gen l. Mgr., Polymers N/A Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 0.00
Mar 24, 2025 Sean T. Moriarty VP & GM Surfactants N/A Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 0.00
Mar 24, 2025 Luis E. Rojo President & CEO; Director N/A Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 0.00
Mar 24, 2025 Jason Scott Keiper VP & Chief Tech & Sust Officer N/A Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 0.00
Mar 11, 2025 F. Quinn Stepan Director 43,169 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 11, 2025 F. Quinn Stepan Director 45,544 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 11, 2025 F. Quinn Stepan Director 102,946 Bona fide gift 0.00
Mar 6, 2025 Samuel S. Hinrichsen VP & Interim CFO 114 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00

Stepan Co. in the News